Codes / ICD10CM / D01.49

D01.49 Carcinoma in situ of other parts of intestine

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Carcinoma in situ of other parts of intestine
  • Also known as non-invasive cancer of other intestinal segments.

Summary

Carcinoma in situ of other parts of intestine refers to early-stage, non-invasive tumors confined to the lining cells of specific intestinal segments not otherwise specified. The abnormal cells have not invaded deeper tissues or spread to other parts of the body, but they have the potential to progress to invasive cancer if left untreated. This condition is considered pre-cancerous and may be detected during routine screening or evaluation for related symptoms.

Causes

The exact causes of carcinoma in situ in these intestinal areas are not fully understood, but they may involve DNA mutations in the lining cells. Prolonged exposure to carcinogens, such as certain dietary factors or chronic inflammation, is believed to contribute to the development of these lesions.

Risk Factors

  • Tobacco use (smoking or chewing)
  • Excessive alcohol consumption
  • Chronic inflammatory conditions (e.g., inflammatory bowel disease)
  • Poor diet (low in fiber, high in processed foods)
  • Age (more common in older adults)
  • Family history of intestinal cancers

Symptoms

  • Often asymptomatic in early stages
  • Vague abdominal pain or discomfort
  • Unexplained weight loss
  • Changes in bowel habits (e.g., diarrhea, constipation)
  • Blood in stool (occasionally)

Diagnosis

Diagnosis typically involves endoscopy with biopsy, where tissue samples are examined for atypical cells. Imaging studies such as CT scans or colonoscopy may be used to assess the extent of the lesion and rule out invasive cancer.

Treatment Options

Treatment often involves surgical removal of the affected segment or localized excision. Endoscopic techniques may be used for smaller lesions. Regular follow-up is recommended to monitor for recurrence or progression.

Prognosis and Follow-Up

Prognosis is generally favorable when treated early, as carcinoma in situ has not invaded surrounding tissues. Follow-up care includes periodic screenings and monitoring for signs of progression to invasive cancer.

Complications

If left untreated, carcinoma in situ may progress to invasive cancer, which can spread to other parts of the body. Rarely, it may cause intestinal obstruction or bleeding.

Lifestyle & Prevention

  • Maintain a balanced diet rich in fiber and low in processed foods
  • Avoid tobacco and limit alcohol consumption
  • Manage chronic inflammatory conditions with medical guidance
  • Participate in routine colorectal cancer screenings as recommended

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, changes in bowel habits, or blood in stool. Early evaluation is important for timely diagnosis and treatment.

Tips for Medical Coders

Document the specific intestinal segment affected, as this may impact code assignment. Ensure clinical documentation supports the diagnosis and any associated procedures performed. Verify that the code aligns with the anatomical location and clinical findings.

Book a walkthrough

D01.49 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.